Malacara HJM

Language: Spanish
References: 9
Page: 131-132
PDF size: 55.12 Kb.

Text Extraction

No abstract

REFERENCES

1. Speroff L. The menopause. A signal for the future. En R. A. Lobo (ed). Treatment of the postmenopausal women: Basic and clinical aspects. Raven Press. New York. 1994.

2. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: stages of reproductive aging workshop (STRAW). Fertil Steril 2001; 76: 874-878.

3. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas 2002; 42: 195-200.

4. Velasco E, Malacara JM, Cervantes F, Díaz de León J, Dávalos G, Castillo J. Gonadotropins and prolactin serum levels during the perimenopausal period: Correlation with diverse factors. Fertil Steril 1990; 53: 56-60.

5. Malacara JM, Fajardo ME, Nava LE. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids 2001; 66: 559-567.

6. Burger HG, Dudley EC, Hopper JL, Schelley JM, Green A, Smith A, Dennerstein L, Morse C. The endocrinology of menopausal transition. A cross- sectional study of a population based study. J Clin Endocrinol Metab 1995; 80: 3537-1345.

7. Burger HG, Dudley EC, Hopper JL, Groome N, Guthrie JR, Green A, Dennerstein L. Prospectively measured levels of serum follicle stimulating hormone, estradiol, and the dimeric inhibin during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999; 84: 4025-4030.

8. Huerta R, Malacara JM, Fajardo ME, Nava LE, Bocanegra A, Sánchez J. High frequency FSH and LH pulses in obese menopausal women. Endocrine 1997; 7: 281-286.

9. Malacara JM, Canto de Cetina T, Bassol S, González N, Cacique L, Vera-Ramírez ML, Nava LE. Symptoms at preand postmenopause in rural and urban women from three States of Mexico. Maturitas 2002; 43: 11-19.